Coral Laboratories [CORALAB] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison

Coral Laboratories
BSE
Loading...

Sequent Scientific
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Coral Laboratories wins in 15 metrics, Sequent Scientific wins in 4 metrics, with 0 ties. Coral Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Coral Laboratories | Sequent Scientific | Better |
---|---|---|---|
P/E Ratio (TTM) | 7.14 | 154.18 | Coral Laboratories |
Price-to-Book Ratio | 0.86 | 6.24 | Coral Laboratories |
Debt-to-Equity Ratio | 1.77 | 62.47 | Coral Laboratories |
PEG Ratio | 8.30 | 1.29 | Sequent Scientific |
EV/EBITDA | 3.87 | 29.36 | Coral Laboratories |
Profit Margin (TTM) | 17.54% | 1.85% | Coral Laboratories |
Operating Margin (TTM) | 9.19% | 7.56% | Coral Laboratories |
EBITDA Margin (TTM) | 9.19% | 7.56% | Coral Laboratories |
Return on Equity | 12.01% | 2.84% | Coral Laboratories |
Return on Assets (TTM) | 10.53% | 1.37% | Coral Laboratories |
Free Cash Flow (TTM) | $-41.67M | $442.73M | Sequent Scientific |
Dividend Yield | 0.34% | N/A | N/A |
1-Year Return | -46.90% | 5.62% | Sequent Scientific |
Price-to-Sales Ratio (TTM) | 1.69 | 2.74 | Coral Laboratories |
Enterprise Value | $685.43M | $48.76B | Sequent Scientific |
EV/Revenue Ratio | 0.67 | 3.04 | Coral Laboratories |
Gross Profit Margin (TTM) | 48.21% | 46.86% | Coral Laboratories |
Revenue per Share (TTM) | $286 | $64 | Coral Laboratories |
Earnings per Share (Diluted) | $67.61 | $1.14 | Coral Laboratories |
Beta (Stock Volatility) | 0.68 | 0.91 | Coral Laboratories |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Coral Laboratories vs Sequent Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Coral Laboratories | -0.56% | -13.11% | -17.08% | -34.91% | -38.74% | -40.76% |
Sequent Scientific | 0.48% | 1.51% | -5.78% | -0.25% | 17.84% | -4.22% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Coral Laboratories | -46.90% | 89.29% | 59.31% | -5.81% | 363.91% | 383.43% |
Sequent Scientific | 5.62% | 52.82% | 30.86% | 19.51% | 19.51% | 19.51% |
Performance & Financial Health Analysis: Coral Laboratories vs Sequent Scientific
Metric | CORALAB | SEQUENT |
---|---|---|
Market Information | ||
Market Cap | ₹1.72B | ₹43.92B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 2,320 | 740,868 |
90 Day Avg. Volume | 1,350 | 544,283 |
Last Close | ₹480.00 | ₹177.04 |
52 Week Range | ₹471.00 - ₹999.00 | ₹117.35 - ₹240.70 |
% from 52W High | -51.95% | -26.45% |
All-Time High | ₹1,190.00 (Jul 24, 2017) | ₹336.50 (Jun 28, 2021) |
% from All-Time High | -59.66% | -47.39% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.41% | 0.13% |
Quarterly Earnings Growth | -0.71% | 1.20% |
Financial Health | ||
Profit Margin (TTM) | 0.18% | 0.02% |
Operating Margin (TTM) | 0.09% | 0.08% |
Return on Equity (TTM) | 0.12% | 0.03% |
Debt to Equity (MRQ) | 1.77 | 62.47 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹562.96 | ₹28.19 |
Cash per Share (MRQ) | ₹300.75 | ₹2.52 |
Operating Cash Flow (TTM) | ₹106.44M | ₹360.47M |
Levered Free Cash Flow (TTM) | ₹241.56M | ₹218.78M |
Dividends | ||
Last 12-Month Dividend Yield | 0.34% | N/A |
Last 12-Month Dividend | ₹2.00 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Coral Laboratories vs Sequent Scientific
Metric | CORALAB | SEQUENT |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 7.14 | 154.18 |
Forward P/E | 8.30 | 34.81 |
PEG Ratio | 8.30 | 1.29 |
Price to Sales (TTM) | 1.69 | 2.74 |
Price to Book (MRQ) | 0.86 | 6.24 |
Market Capitalization | ||
Market Capitalization | ₹1.72B | ₹43.92B |
Enterprise Value | ₹685.43M | ₹48.76B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 0.67 | 3.04 |
Enterprise to EBITDA | 3.87 | 29.36 |
Risk & Other Metrics | ||
Beta | 0.68 | 0.91 |
Book Value per Share (MRQ) | ₹562.96 | ₹28.19 |
Financial Statements Comparison: Coral Laboratories vs Sequent Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | CORALAB | SEQUENT |
---|---|---|
Revenue/Sales | ₹281.35M | ₹4.41B |
Cost of Goods Sold | ₹145.71M | ₹2.35B |
Gross Profit | ₹135.64M | ₹2.07B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹21.79M | ₹333.50M |
EBITDA | ₹51.66M | ₹505.30M |
Pre-Tax Income | ₹38.52M | ₹255.20M |
Income Tax | ₹10.25M | ₹79.50M |
Net Income (Profit) | ₹28.27M | ₹175.70M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | CORALAB | SEQUENT |
---|---|---|
Cash & Equivalents | ₹34.06M | ₹626.60M |
Total Current Assets | ₹1.77B | ₹8.74B |
Total Current Liabilities | ₹249.58M | ₹5.05B |
Long-Term Debt | ₹0 | ₹3.00B |
Total Shareholders Equity | ₹2.01B | ₹7.70B |
Retained Earnings | N/A | ₹1.25B |
Property, Plant & Equipment | ₹217.44M | ₹2.84B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | CORALAB | SEQUENT |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | CORALAB | SEQUENT |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 2,320 | 740,868 |
Average Daily Volume (90 Day) | 1,350 | 544,283 |
Shares Outstanding | 3.57M | 249.89M |
Float Shares | 806,826 | 117.77M |
% Held by Insiders | 0.78% | 0.53% |
% Held by Institutions | 0.00% | 0.13% |
Dividend Analysis & Yield Comparison: Coral Laboratories vs Sequent Scientific
Metric | CORALAB | SEQUENT |
---|---|---|
Last 12-Month Dividend | ₹2.00 | ₹0.00 |
Last 12-Month Dividend Yield | 0.34% | N/A |
3-Year Avg Annual Dividend | ₹0.67 | ₹0.00 |
3-Year Avg Dividend Yield | 0.22% | N/A |
3-Year Total Dividends | ₹2.00 | ₹0.00 |
Ex-Dividend Date | Sep 20, 2024 | N/A |